Entyvio: Hyper-Focus on the Patient Journey

Takeda Pharmaceuticals, a pharmaceutical company, increased registrations for its Entyvio Connect program in the US by creating new datasets to inform a programmatic display and video outreach.

Summary

A Journey Challenge: Entyvio is a biologic indicated for Crohn's Disease and Ulcerative Colitis and is typically prescribed for moderatetosevere sufferers who have failed on more conservative therapies. Therefore, these sufferers are bio-naïve in that they have no experience with biologic treatments and have failed on conventional therapies. However, they are NOT condition-naïve. In fact, they are quite familiar with their condition and how it impacts their life.

Our Strategic Response:Hyper-focus on the point in the patient journey when they'll be most receptive to a new treatment approach – shift the focus from initial diagnosis to their first...

Not a subscriber?

Schedule your live demo with our team today

WARC helps you to plan, create and deliver more effective marketing

  • Prove your case and back-up your idea

  • Get expert guidance on strategic challenges

  • Tackle current and emerging marketing themes

We’re long-term subscribers to WARC and it’s a tool we use extensively. We use it to source case studies and best practice for the purposes of internal training, as well as for putting persuasive cases to clients. In compiling a recent case for long-term, sustained investment in brand, we were able to support key marketing principles with numerous case studies sourced from WARC. It helped bring what could have been a relatively dry deck to life with recognisable brand successes from across a broad number of categories. It’s incredibly efficient to have such a wealth of insight in one place.

Insights Team
Bray Leino

You’re in good company

We work with 80% of Forbes' most valuable brands* and 80% of the world's top top-of-the-class agencies.

* Top 10 brands